Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: CareDx Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
CareDx Inc. June 13, 202485.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | CareDx Inc. | Option exercise | +15,000 | $14.74 | $221,100 |
| Aug 5, 2026 | CareDx Inc. | Open-market sale | −20,000 | $46.29 | $925,800 |
| Jun 12, 2026 | CareDx Inc. | Grant or award | +9,795 | — | — |
| Sep 11, 2025 | CareDx Inc. | Option exercise | +29,136 | $7.96 | $231,923 |
| Jun 13, 2025 | CareDx Inc. | Grant or award | +12,103 | — | — |
| Mar 10, 2025 | CareDx Inc. | Open-market sale | −20,000 | $18.36 | $367,200 |
| Nov 1, 2024 | CareDx Inc. | Option exercise | +5,255 | $5.85 | $30,742 |
| Nov 1, 2024 | CareDx Inc. | Option exercise | +2,226 | $5.49 | $12,221 |
| Jun 14, 2024 | CareDx Inc. | Grant or award | +10,570 | — | — |
| May 14, 2024 | CareDx Inc. | Option exercise | +5,255 | $10.00 | $52,550 |
| Aug 11, 2023 | CareDx Inc. | Option exercise | +5,255 | $5.02 | $26,380 |
| Aug 11, 2023 | CareDx Inc. | Option exercise | +9,745 | $4.95 | $48,238 |
| Aug 11, 2023 | CareDx Inc. | Option exercise | +4,453 | $5.49 | $24,447 |
| Jun 16, 2023 | CareDx Inc. | Grant or award | +18,844 | — | — |
| Jan 6, 2023 | CareDx Inc. | Grant or award | +1,323 | — | — |
Questions about George Bickerstaff
What boards is George Bickerstaff on?
George Bickerstaff sits on the board of CareDx Inc.
How long has George Bickerstaff served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.